Semax, a synthetic peptide derived from ACTH, has been studied for cognitive enhancement, neuroprotection, and attention support
On average, patients can expect to lose 5-10% of their initial body weight over six months, though some may experience more substantial results
SGLT2 [sodium-glucose cotransporter 2] inhibitors initially seemed to be linked with an even lower risk of uveitis compared to GLP-1 receptor agonists, but after doing a sensitivity analysis of patients on monotherapy, we no longer found that association
Other controlled clinical trials with different measurable outputs are needed to further evaluate the efficacy of glutathione as a skin-lightening agent
It is neither an insurance company nor a regulatory agency
If so, even a small contribution helps me keep content like this going